Nicholas Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-37,254
Closed -$2.95M 298
2016
Q4
$2.95M Buy
+37,254
New +$2.95M 0.22% 188
2016
Q1
Sell
-48,556
Closed -$4.31M 341
2015
Q4
$4.31M Sell
48,556
-4,513
-9% -$400K 0.3% 140
2015
Q3
$3.93M Buy
53,069
+1,314
+3% +$97.3K 0.28% 146
2015
Q2
$4.19M Sell
51,755
-1,945
-4% -$157K 0.27% 133
2015
Q1
$2.25M Buy
+53,700
New +$2.25M 0.14% 253